SPI1 and Alzheimer disease: Finally, we demonstrate that several of these PU.1-regulated genes are expressed and upregulated by microglia in the human AD brain and suggest that modulating PU.1 expression may be a valid therapeutic target to prevent microglial-mediated neurodegeneration.